USF-LVHN SELECT
Primary Progression on Frontline Therapy for Diffuse Large B-Cell Lymphoma Is Associated with a Poor Outcome Despite Subsequent CD19 Targeted CAR T-Cell Therapy
Publication/Presentation Date
11-2021
Volume
138
Issue
1
First Page
3855
Last Page
3855
Published In/Presented At
Disciplines
Medical Education | Medicine and Health Sciences
Department(s)
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students
Document Type
Article
COinS